Cargando…

Translational Research in Alzheimer’s and Prion Diseases

Translational neuroscience integrates the knowledge derived by basic neuroscience with the development of new diagnostic and therapeutic tools that may be applied to clinical practice in neurological diseases. This information can be used to improve clinical trial designs and outcomes that will acce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Fede, Giuseppe, Giaccone, Giorgio, Salmona, Mario, Tagliavini, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5869996/ https://www.ncbi.nlm.nih.gov/pubmed/29172000 http://dx.doi.org/10.3233/JAD-170770

Ejemplares similares

Dreaming of a New World Where Alzheimer’s Is a Treatable Disorder
por: Catania, Marcella, et al.
Publicado: (2019)

Serpin Signatures in Prion and Alzheimer’s Diseases
por: Zattoni, Marco, et al.
Publicado: (2022)

Microglial Heterogeneity and Its Potential Role in Driving Phenotypic Diversity of Alzheimer’s Disease
por: Sorrentino, Stefano, et al.
Publicado: (2021)

A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer’s disease
por: Catania, Marcella, et al.
Publicado: (2022)

Lipofuscin Hypothesis of Alzheimer's Disease
por: Giaccone, Giorgio, et al.
Publicado: (2011)

Tackling amyloidogenesis in Alzheimer’s disease with A2V variants of Amyloid-β
por: Di Fede, Giuseppe, et al.
Publicado: (2016)

Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer’s Disease and Other Neurological Disorders
por: Bellomo, Giovanni, et al.
Publicado: (2021)

Molecular subtypes of Alzheimer’s disease
por: Di Fede, Giuseppe, et al.
Publicado: (2018)

The Efficacy of Tetracyclines in Peripheral and Intracerebral Prion Infection
por: De Luigi, Ada, et al.
Publicado: (2008)

Conversion of the BASE Prion Strain into the BSE Strain: The Origin of BSE?
por: Capobianco, Raffaella, et al.
Publicado: (2007)

PMCA Applications for Prion Detection in Peripheral Tissues of Patients with Variant Creutzfeldt-Jakob Disease
por: Giaccone, Giorgio, et al.
Publicado: (2020)

Clinical and neuropathological phenotype associated with the novel V189I mutation in the prion protein gene
por: Di Fede, Giuseppe, et al.
Publicado: (2019)

PMCA-Based Detection of Prions in the Olfactory Mucosa of Patients With Sporadic Creutzfeldt–Jakob Disease
por: Cazzaniga, Federico Angelo, et al.
Publicado: (2022)

Corrigendum: PMCA-based detection of prions in the olfactory mucosa of patients with sporadic Creutzfeldt–Jakob disease
por: Cazzaniga, Federico Angelo, et al.
Publicado: (2023)

Psychological Impact of Predictive Genetic Testing for Inherited Alzheimer Disease and Frontotemporal Dementia: The IT-DIAfN Protocol
por: Galluzzi, Samantha, et al.
Publicado: (2022)

Mathematical models for the diffusion magnetic resonance signal abnormality in patients with prion diseases
por: Figini, Matteo, et al.
Publicado: (2014)

Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
por: Hannaoui, Samia, et al.
Publicado: (2014)

The A2V mutation as a new tool for hindering Aβ aggregation: A neutron and x-ray diffraction study
por: Cantu’, Laura, et al.
Publicado: (2017)

Differential overexpression of SERPINA3 in human prion diseases
por: Vanni, S., et al.
Publicado: (2017)

Singular cases of Alzheimer’s disease disclose new and old genetic “acquaintances”
por: Coppola, Cinzia, et al.
Publicado: (2020)

Microbiome Influence in the Pathogenesis of Prion and Alzheimer’s Diseases
por: D’Argenio, Valeria, et al.
Publicado: (2019)

Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease
por: Bistaffa, Edoardo, et al.
Publicado: (2020)

Ginkgolide B inhibits the neurotoxicity of prions or amyloid-β(1-42)
por: Bate, Clive, et al.
Publicado: (2004)

Prions, prionoids and pathogenic proteins in Alzheimer disease
por: Ashe, Karen H., et al.
Publicado: (2013)

PMCA-generated prions from the olfactory mucosa of patients with Fatal Familial Insomnia cause prion disease in mice
por: Bistaffa, Edoardo, et al.
Publicado: (2021)

Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells
por: Bate, Clive, et al.
Publicado: (2008)

Synthetic prions with novel strain-specified properties
por: Moda, Fabio, et al.
Publicado: (2015)

Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
por: Milisav, Irina, et al.
Publicado: (2015)

Expression of A2V-mutated Aβ in Caenorhabditis elegans results in oligomer formation and toxicity()
por: Diomede, Luisa, et al.
Publicado: (2014)

Spontaneous intracerebral haemorrhage associated with early-onset cerebral amyloid angiopathy and Alzheimer’s disease neuropathological changes five decades after cadaveric dura mater graft
por: Milani, Riccardo, et al.
Publicado: (2023)

Recommendations for addressing the translational gap between experimental and clinical research on amyloid diseases
por: Solomon, Miriam, et al.
Publicado: (2022)

Photobiomodulation for Alzheimer’s Disease: Translating Basic Research to Clinical Application
por: Enengl, Joachim, et al.
Publicado: (2020)

α-Synuclein Amyloids Hijack Prion Protein to Gain Cell Entry, Facilitate Cell-to-Cell Spreading and Block Prion Replication
por: Aulić, Suzana, et al.
Publicado: (2017)

Establishment of a Special Platform for the Research of Prion and the Diagnosis of Human Prion Disease — China’s Studies
por: Xiao, Kang, et al.
Publicado: (2022)

Dual role of cellular prion protein in normal host and Alzheimer’s disease
por: ONODERA, Takashi
Publicado: (2017)

The Contribution of the Amyloid Hypothesis to the Understanding of Alzheimer's Disease: A Critical Overview
por: Morelli, Laura, et al.
Publicado: (2012)

MicroRNAs in Prion Diseases—From Molecular Mechanisms to Insights in Translational Medicine
por: Contiliani, Danyel Fernandes, et al.
Publicado: (2021)

Defined α-synuclein prion-like molecular assemblies spreading in cell culture
por: Aulić, Suzana, et al.
Publicado: (2014)

Prions and Prion Diseases: Current Perspectives
por: Belay, Ermias D.
Publicado: (2004)

Modeling Prion-Like Processing of Tau Protein in Alzheimer’s Disease for Pharmaceutical Development
por: Wischik, Claude M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3qdjdc206eh6hq94g8svmfu97d